SHS Gesellschaft, a German private equity firm, has acquired a majority stake in TNI Medical AG, German maker of diagnostic and therapeutic equipment for breathing therapy.
Funds provided by SHS Gesellschaft für Beteiligungsmanagement, a growth investor in Tübingen, by KfW Bankengruppe (ERP Start Fund) and by managers, have been used to purchase a majority share in TNI medical AG, a medical technology firm. TNI medical AG develops, produces and sells diagnostic and therapeutic equipment for breathing therapy. As part of the current infusion of financing, nearly the company is providing EUR 2 million to promote continued growth.
With headquarters in Freiburg and Würzburg, Germany, TNI medical AG was established in autumn of 2007 and develops technologies for mechanical breathing therapy. The syndromes of sleep apnoea and chronic obstructive pulmonary disease primarily treated using applications by TNI medical currently exhibit high growth in the rates of incidence worldwide. The therapeutic products provided by TNI medical are
focused on in-home treatment of patients, particularly during sleep.
‘Products by TNI medical increase patient comfort while simplifying application at the same time. This also promotes cost-efficiency. Accordingly, we anticipate strong growth in demand for these products,
particularly in the home-care market. We welcome the opportunity to continue to accompany CEO Ewald Anger and his team through continued growth at the company’, observes Hubertus Leonhardt, partner at SHS Gesellschaft für Beteiligungsmanagement, commenting on the investment in TNI medical AG.
‘In SHS, we have found a committed investor, one with proven competence in the medical-technology area and a successful track record in helping set up numerous new companies. With SHS backing us up, we can continue to rev up our operation’, notes TNI medical AG CEO Ewald Anger with regard to the company’s new lead investor.
About SHS Gesellschaft für Beteiligungsmanagement mbH
Founded in Tübingen in 1993, SHS Gesellschaft für Beteiligungsmanagement provides financing and consulting to new companies in the industries of the future, particularly in the healthcare and life sciences areas. With the investment funds it has launched to date, SHS manages around EUR 120 million in investment capital. Lead partners are former McKinsey consultants Bernhard Schirmers and Reinhilde Spatscheck, as well as Hubertus Leonhardt, formerly Corporate Finance Project Manager at Arthur Andersen.
Investors have made some EUR 50 million available for the current SHS III Fund. Investors include the European Investment Fund (EIF), through which the SHS Fund receives funding from the ERP-EIF Fund of Funds and from the ‘Competitiveness and Innovation Framework Programme’ (CIP) of the European Union; KfW Bankengruppe; a pension fund, a fund of funds and various businesspersons, family offices and the SHS
management team itself.